In season 1, episode 2 of the popular show “The Pitt,” a Black woman with sickle cell disease arrives at the emergency department in acute pain, only to be initially dismissed as drug-seeking. “Unfortunately, this […]
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome—a common and often painful complication suffered by many people who have experienced blockages […]
Marriage, it turns out, may come with a side-effect no one puts in the vows: people who have been married seem less likely to develop cancer than those who have never married at all.This article […]
New findings reveal that obesity significantly impaired the quality and longevity of antibody responses to a Pseudomonas aeruginosa vaccine in a mouse model. The impaired antibody production was due to defects in germinal centers, a […]
Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today at EHRA 2026 the annual congress of the European Heart Rhythm Association (EHRA), a branch of the […]
Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, making up 47% of new diagnoses, according to research published in CMAJ (Canadian Medical Association […]
Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in the Canadian Medical Association Journal. Primary neoplasms—new […]
New research being presented at this year’s European Congress on Obesity (ECO) in Istanbul, Turkey (May 12–15), reveals distinct patterns of heart, metabolic, and inflammatory health risks between men and women living with obesity, providing […]
A clinical trial led by UT Southwestern Medical Center researchers demonstrates that providing healthy food directly to patients recovering from heart failure is feasible and well accepted—and could improve quality of life—helping build a foundation […]
Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented the virus from developing drug resistance—a persistent problem with current therapies for infants. RSV is […]
© 2025 SimplyWell.ca